ArticleFrontiers in chemistry2025
Sensitive immunosensing of melanoma biomarker based on enhanced electrochemiluminescence via electronic metal-support interactions.
Article in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Enzymatic electrochemiluminescence sensor based on a ternary luminol-HRSC advances · 2026Article
- Enhanced Electrochemiluminescence by Nanocatalyst-Supported Nanochannel-Surfactant Micelle Assembly for Ultrasensitive Detection of Rifampicin.Biosensors · 2026Article
- Triple-enrichment interface enabled by surfactant-modified carbon nanotube for signal-off electrochemiluminescence detection of antitumor drug mitoxantrone.Frontiers in chemistry · 2026Article
- CuFrontiers in chemistry · 2026Article
- AuPt bimetallic nanocatalyst-amplified luminol-dissolved oxygen electrochemiluminescence for interferon-γ immunosensing.Frontiers in chemistry · 2026Article
- Internal probe-external recognition immunosensor fabricated on nanochannels for reagent-free electrochemical detection of interleukin-1β.RSC advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Developing highly sensitive and convenient immunosensor for the detection of biomarker is important for enhancing the effectiveness of melanoma prevention and control measures. In this work, immunosensor was fabricated for sensitive detection of the melanoma biomarker S100B based on enhanced electrochemiluminescence (ECL) via electronic metal-support interactions. CoAl-layered double hydroxide (LDH) was selected as to modify the costless indium tin oxide (ITO) electrode due to its high surface area and tunable structure. To improve its conductivity and electron transfer capability, oxygen vacancies (Ov) were introduced on LDH through an alkaline etching process, resulting in the LDH-Ov structure. Platinum nanoparticles (Pt) were then
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.